People who inject drugs (PWID) experience a range of barriers to HIV treatment and care access. The Kenyan government and community-based organisations have sought to develop HIV care for PWID. A principal approach to delivery in Kenya is to provide care from clinics serving the general population and for this to be linked to support from community-based organisations providing harm reduction outreach. This study explores accounts of PWID accessing care in Kenya to identify care barriers and facilitators. PWID accounts were collected within a qualitative longitudinal study. In-depth interviews with PWID living with HIV (n = 44) are combined with interviews with other PWID, care providers and community observation. Results show that some PWID are able to access care successfully, whilst other PWID report challenges. The results focus on three principal themes to give insights into these experiences: the hardship of addiction and the costs of care, the silencing of HIV in the community and then discrimination and support in the clinic. Some PWID are able to overcome, often with social and outreach support, barriers to clinic access; for others, the challenges of addiction, hardship, stigma and discrimination are too constraining. We discuss how clinics serving the general population could be further adapted to increase access. Clinic-based care, even with community links, may, however, be fundamentally challenging for some PWID to access. Additional strategies to develop stand-alone care for PWID and also decentralise HIV treatment and care to community settings and involve peers in delivery should be considered.
Introduction
HIV treatment and care access for People Who Inject Drugs (PWID) is a major challenge globally (Feelemyer, Des Jarlais, Arasteh, & Uusküla, 2015) . In Kenya, HIV prevalence for PWID is estimated at 18.3%, and 44% for women (Kurth et al., 2015; National AIDS Control Council, 2014; Tun et al., 2015) , with just 8% of PWID in Nairobi living with HIV accessing ART in 2012 (Rhodes et al., 2015a) .
PWIDs' access to HIV treatment is limited by social and structural factors (Grubb et al., 2014) including norms and understandings of treatment, social exclusion and stigma, drug policy, homelessness and criminalisation (Krüsi, Wood, Montaner, & Kerr, 2010; Rhodes & Sarang, 2012; Wolfe, Carrieri, & Shepard, 2010) .
The Kenyan government and partner communitybased organisations (CBOs) are seeking to respond to potential barriers and provide accessible HIV care for PWID. The principal mode of delivery for ART and ongoing HIV careincluding initiation and prescription of medications, counselling, CD4 testingis through fixed site HIV-focused clinics serving the general population. Drug and harm reduction-focused CBOs support care access through outreach or from "drop-in centres" with interventions such as counselling and assisted referrals (Lizcano, Muluve, Cleland, Kurth, & Cherutich, 2014) and ART delivery from one drop-in centre is also being piloted.
We explore accounts of PWID accessing care in Kenya to identify care barriers and facilitators in order to support the future development of services.
Methods
We report analysis of data collected through a longitudinal qualitative study that explored the social contexts for drug use and HIV risk in Kenya (Guise, Dimova, Ndimbii, Clark, & Rhodes, 2015; Ndimbii et al., 2016; Rhodes et al., 2015a; Rhodes, Ndimbii, Guise, Cullen, & Ayon, 2015b) . The study was implemented across three sites in Kenya: Nairobi, Malindi and Ukunda, in partnership with Nairobi Outreach Services Trust (NOSET), The Omari Project and Teenswatch, respectively. There were three waves of data collection between December 2012 and January 2014.
In-depth interviews with PWID explored experiences of HIV care as well as drug use, drug treatment, the emerging needle and syringe programme, and other issues as raised by respondents. Interviews were semi-structured and started with open questions around a respondent's current concerns and situation around their drug use, before investigating specific themes of interest. Interviews were conducted in English or Swahili. Sampling for wave one of data collection was purposive, seeking a range of experiences according to gender and age. Later sampling was theoretical and sought to explore specific experiences.
PWID interviews were supplemented by observation in community settings, including drug using sites, and interviews with healthcare providers and staff working in community-based outreach projects (n = 15). All participants gave informed consent. Interviews were audio-recorded, transcribed and translated in to English where necessary. All names used are pseudonyms to maintain confidentiality.
The analysis presented here focuses on accounts of PWID living with HIV (see Table 1 ). Of the 118 people who use drugs interviewed, 44 disclosed that they were living with HIV. A thematic analysis (Ezzy, 2002) approach was used. PWID LHIV accounts were open coded, with coding driven by focus issues for respondents and evidence from existing literature; these codes were triangulated with experiences from other PWID, providers and outreach staff, and community observation. The codes were then grouped in to overarching themes.
Findings
We developed three themes that give insight into PWID experiences of care. Table 2 has illustrative data extracts.
The hardship of addiction and the costs of care
The hardships of living with addictionwithdrawal pains and poverty, and the related need to constantly seek money (commonly through casual labour, sex work or petty crime)were described as not possible by some to reconcile with the demands of clinic-based care: "You go for money, or you go to the hospital." Whilst HIV care is free, the costs of travel to clinics was often viewed as prohibitive: "I have to go to [nearby town], sometimes I don't have fees to go there." Time spent queuing at the clinic is also a "cost", taking time away from sourcing money. Arrangements between clinics and community-based outreach projects helped to overcome barriers of time, cost and queuing. There were adjustments to clinic routines such as priority for PWID within queues when accompanied by an outreach worker and assistance with transport by outreach projects to the clinic. The piloting of ART delivery at a community-based dropin centre was welcomed for its ease of access: "I think it is good because this place is near … it is just here." For some, their experience of addiction meant that they could not prioritise care even with this support. Outreach projects also were not always able to offset cost constraints PWID faced through having limited funding themselves.
Drug treatment through residential rehabilitation was one route allowing people to prevent addiction limiting care access, although the long-term effects of this could be limited and it was prohibitively expensive for most (Rhodes et al., 2015b) . A few PWID, even whilst still actively using drugs, described how they could "find the time" to get to clinics and struggle to source food to enable treatment access.
The silencing of HIV in the community
Some feared disclosing their HIV status to intimate partners, family, outreach projects or the community, so limiting seeking care. HIV is seemingly rarely discussed openly amongst PWID, with people reporting they did not know which other PWID were HIV positive. Such discretion and secrecy arises from a context where being HIV positive could be seen as a symbol of being "already dead". Social isolation was not total for PWID LHIV, with hopeful interpretations of HIV available and linked to support from family, friends and other people injecting drugs.
Discrimination and support in the clinic
Not attending a clinic and not wanting to seek care was linked to a fear or experience of discrimination. Some managed this potential for stigma and discrimination by hiding their injecting drug use from providers. Others spoke of HIV clinics as accepting, "respectful" of PWID and treating people as "human": "Those who distribute the medicine are courteous. The doctors who treat and give us medicine don't look down upon us."
Discussion
Some PWID in Kenya describe successfully engaging with HIV care in clinics serving the general population and overcoming barriers of travel, time and stigma. Outreach support is instrumental for some (Needle et al., 2005) , while others draw on support from family, friends and providers. These findings also draw attention to social and structural barriers to care access in Kenya (Krüsi et al., 2010) : deferring treatment under the weight of addiction, the direct and indirect costs for clinic access, and fears and experiences of stigma from PWID, the community and care providers.
Adaptations to clinics serving the general population care could further support access for PWID (Beyrer et al., 2011) , for example, extended opening hours and training of providers. Enabling interventions such as sufficient resourcing of CBOs supporting harm reduction efforts (Harm Reduction International, International Drug Policy Consortium & International HIV/AIDS Alliance, 2014), action on stigma (Stangl, Lloyd, Brady, Holland, & Baral, 2013) , the recent introduction of methadone (Rhodes et al., 2015a) and action to address PWID poverty (Ogembo, Angira, Mbugua, Abdallah, & Abdool, 2014) could also support this clinic access.
The distance, costs and fear of stigma may, however, fundamentally limit for some PWID the potential to access clinics that serve the general population. Care models are needed that respond to a diversity of experiences: "one size does not fit all" (Beyrer et al., 2011) . "Stand-alone" care for PWIDthat is, separate from care for the general populationcould be acceptable for some, including in the context of methadone as now emerging in Kenya and previously introduced in Tanzania (Bruce et al., 2014) .
Decentralised HIV treatment and care delivery in community-based centres and mobile clinics (Altice et al., 2004; WHO et al., 2014) would also respond to structural challenges of cost, time and stigma in clinics. This decentralised support could include ART delivery from outreach drop in sites as currently piloted, and also peer support roles, such as community ART groups or distribution points (Bemelmans et al., 2014) . Community delivery and task shifting to PWID could also be instrumental in tackling stigma (Ti & Kerr, 2013) .
The study was limited by the contingencies of research with a highly marginalised population; heroin withdrawals and the demands of addiction often limited time in interviews and follow-up was limited by migration and incarceration. The analysis still provides an in-depth insight into PWID experiences of HIV care access.
Conclusions
Community-supported clinic-based HIV care serving the general population is accessible for some PWID in Kenya, but the structural and social barriers of distance, time and community and facility-level stigma and discrimination limit care for others. Clinics should adapt further, as well as develop additional entry points for care, including stand-alone care and decentralised community-level delivery.
